Abstract:Radioactive iodine is used mostly in treating differentiated thyroid cancer(DTC) with a therapeutic intent, while PET/CT with 18F-FDG emerges as a useful tool in the diagnostic management and complements the use of radioactive iodine. The PET/MR imaging may provide a new imaging technique for the diagnosis, treatment or disease assessment of the DTC. This article mainly reviews the physical and biological characteristics of several currently available radiopharmaceuticals(including various tracers such as 18F-FDG, 124I, 18F-TFB and 68Ga-PSMA), and their combination with the most advanced technology provides new possibilities for the diagnosis, treatment and follow-up of DTC patients.
